Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Stomatitis 2Mucositis 2Head and Neck Neoplasms 2Signs and Symptoms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neuroblastoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Metabolic Diseases 1Lymphoma 1Leukemia, Myeloid, Acute 1Immunologic Deficiency Syndromes 1Hepatoblastoma 1Anemia, Refractory, with Excess of Blasts 1Anemia, Aplastic 1

Interventions

Vincristine 12Temozolomide 11Irinotecan 10Cyclophosphamide 10Melphalan 8Filgrastim 8Etoposide 7Ifosfamide 6Granulocyte Colony-Stimulating Factor 6Doxorubicin 6Vinorelbine 5Gemcitabine 5Busulfan 5Thiotepa 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Dactinomycin 4pegfilgrastim 3liposomal doxorubicin 3irinotecan sucrosofate 3fludarabine 3etoposide phosphate 3Stem Cell Transplantation 3Sirolimus 3Proton Therapy 3Cisplatin 3Carboplatin 3Bone Marrow Transplantation 3thymoglobulin 2regorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Rhabdomyosarcoma × Honey × Clear all
NCT01804634 2026-03-13

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
60 enrolled
CNSGastrointestinalSarcoma

Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡